Galenica

1. Fluctuations in the pricing of pharmaceutical products: The cost of pharmaceuticals products may be subject to significant fluctuations caused by changes in governmental regulations, developments in the competitive environment, and other market pressures.

2. Regulatory risks: Government regulations related to the pricing, distribution, and marketing of pharmaceuticals can change rapidly and can be costly and difficult to implement.

3. Changes in customer requirements and preferences: Customers’ needs and preferences can change quickly, and if Galenica Santé does not respond quickly enough to changes, it may lose customers.

4. Dependence on suppliers: Galenica Santé depends on its suppliers for the supply of raw materials which can be difficult to obtain or of poor quality.

5. Cybersecurity risks: Unified data systems and networks present an increased risk of cyber-attacks which can have serious financial costs.

6. Talent and skill shortages: Due to the rapidly changing nature of the healthcare sector, it can be difficult to recruit and retain qualified staff.

7. Economic cycles: Sudden changes in the macroeconomic environment can significantly effect demand and financial performance.